Synthesis and reactivity of coumarin 3,4-epoxide

Drug Metabolism and Disposition

Volumn 25, Issue 11, 1997, Pages 1318-1323

  Born, Stephanie L ^a   Rodriguez, Pedro A ^b   Eddy, Cynthia L ^b   Lehman Mckeeman, Lois D ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN 3,4 EPOXIDE; COUMARIN ANTICOAGULANT; DIMETHYLDIOXIRANE; UNCLASSIFIED DRUG;

ARTICLE; DRUG CARCINOGENICITY; DRUG METABOLISM; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TOXICITY; LYMPHEDEMA; PRIORITY JOURNAL; SPECIES DIFFERENTIATION;

CHROMATOGRAPHY, GAS; COUMARINS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; SPECTROPHOTOMETRY, INFRARED;

RODENTIA;

EID: 0030671176     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. S. Jamal and J. R. Casley Smith: The effects of 5,6-benzo[a]pyrone (coumarin) and DEC on filaritic lymphoedema and elephantiasis in India, preliminary results. Ann. Trop. Med. Parasitol. 83, 287-290 (1989).
2. M. E. Marshall, K. Butler, J. Cantrell, C. Wiseman, and L. Mendelsohn: Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study. Cancer Chemother. Pharmacol. 24, 65-66 (1989).
3. D. Cox, R. O'Kennedy, and R. D. Thornes: The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Human Toxicol. 8, 501-506 (1989).
4. D. Egan, R. O'Kennedy, E. Moran, D. Cox, E. Prosser, and R. D. Thomes: The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab. Rev. 22, 503-529 (1990).
5. A. J. Cohen: Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food Cosmet. Toxicol. 17, 277-289 (1979).
6. B. G. Lake: Investigations into the mechanism of coumarin-induced hepatotoxicity in the rat. Arch. Toxicol. Suppl. 7, 16-29 (1984).
7. National Toxicology Program Technical Report, 422: Toxicology and carcinogenesis studies of coumarin in F344/N rats and B6C3F1 mice. (1993).
8. J. H. Fentem, J. R. Fry: Species differences in the metabolism and hepatotoxicity of coumarin. Comp. Biochem. Physiol. 104C, 1-8 (1993).
9. B. G. Lake, T. J. B. Gray, J. G. Evans, D. F. V. Lewis, J. A. Beamand, and K. L. Hue: Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites. Toxicol. Appl. Pharmacol. 97, 311-323 (1989).
10. J. A. R. Mead, J. N. Smith, and R. T. Williams: The metabolism of hydroxycoumarins. Biochem. J. 68, 61-67 (1958).
11. W. H. Shilling, R. F. Crampton, and R. C. Longland: Metabolism of coumarin in man. Nature (Lond.) 221, 664-665 (1969).
12. 14C]coumarin. J Med. Pharm. Chem. 3, 25-43 (1961).
13. J. H. Fentem, J. R. Fry, and D. A. Whiting: o-Hydroxyphenylacetaldehyde: a major novel metabolite of coumarin formed by rat, gerbil and human liver microsomes. Biochem. Biophys. Res. Commun. 179, 197-203 (1991).
14. B. G. Lake, D. J. Osborne, D. G. Walters, and R. J. Price: Identification of o-hydroxyphenylacetaldehyde as a major metabolite of coumarin in rat hepatic microsomes. Food Chem. Toxicol. 30, 99-104 (1992).
15. 14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, syrian hamster, gerbil and humans. Food Chem. Toxicol. 30, 105-115 (1992).
16. 14C]coumarin by rat hepatic microsomes. Xenobiotica 21, 499-514 (1991).
17. V. J. Feron, H. P. Til, F. De Vrijer, R. A. Woutersen, F. R. Cassée, and P. J. Van Bladeren: Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259, 363-385 (1991).
18. M. M. Abou-ElZahab: Epoxidation of some skin-photosensitizers and blood anticoagulants of natural coumarin and furocoumarins as potential alkylating agents of DNA. Alex. J. Pharm. Sci. 7, 45-46 (1993).
19. J. M. Bruce, and D. Creed: Light-induced and related reactions of quinones. Part VI. reactions of some p-quinones carrying formyl groups. J. Chem. Soc. 649-653 (1970).
20. S. Maeno, and P. A. Rodriguez: Simple and versatile injection system for capillary gas chromatographic columns: performance evaluation of a system including mass spectrometric and light-pipe Fourier-transform infrared detection. J. Chromatogr. 731, 201-215 (1996).
21. B. B. Brodie, W. Reid, A. K. Cho, I. G. Sipes, G. Krishna, and J. R. Gillette: Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. USA 68, 160-164 (1971).
22. N. Zampaglione, D. J. Jollow, J. R. Mitchell, B. Stripp, M. Hamrick, and J. R. Gillette: Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J. Pharmacol. Exp. Ther. 187, 218-227 (1973).
23. K. W. Bock, G. Van Ackeren, F. Lorch, and F. W. Birke: Metabolism of naphthalene to naphthalene dihydrodiol glucuronide in isolated hepatocytes and in liver microsomes. Biochem. Pharmacol. 25, 2351-2356 (1976).
24. M. D. Tingle, M. Pirmohamed, E. Templeton, A. S. Wilson, S. Madden, N. R. Kitteringham, and B. K. Park: An investigation of the formation of cytotoxic, genotoxic, and protein-reactive and stable metabolites from naphthalene by human liver microsomes. Biochem. Pharmacol. 46, 1529-1538 (1993).
25. T. Huwer, H-J. Altmann, W. Grunow, S. Lenhardt, M. Przybylski, and G. Eisenbrand: Coumarin mercapturic acid isolated from rat urine indicates metabolic formation of coumarin 3,4-epoxide. Chem. Res. Toxicol. 4, 586-590 (1991).
26. R. L. Norman and A. W. Wood: o-Hydroxyphenylethanol, a novel lactone ring-opened metabolite of coumarin. Drug Metab. Dispos. 12, 543-549 (1984).
27. P. Fernandez-Salguero, and F. J. Gonzales: The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics 5, S123-S128 (1995).
28. P. Fernandez-Salguero, S. M. G. Hoffman, S. Cholerton, H. Mohrenweiser, H. Raunio, A. Rautio, O. Pelkonen, J-D. Huang, W. E. Evans, J. R. Idle, and F. J. Gonzales: A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet. 57, 651-660 (1995).